Documentos de Anagnostis P. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Publisher: "Maturitas"

Subtipo de publicación

Área temáticas

Enfermedades(4)

Farmacología y terapéutica(2)

Ginecología, obstetricia, pediatría, geriatría(2)

Medicina y salud(1)

Salud y seguridad personal(1)

Área de conocimiento

Medicina interna(1)

Año de Publicación

Origen

Palabras Claves

menopausal hormone therapy(2)

Bisphosphonates(1)

Cardiovascular disease(1)

Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.

Palabras claves:

Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.

Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement

Abstract: Background Bisphosphonates and denosumab are used extensively in the treatment of postmenopausal ost

Palabras claves:

Alendronate, Bisphosphonates, Denosumab, Drug holiday, Risedronate, Zoledronic acid

Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.

Menopause and diabetes: EMAS clinical guide

Abstract: Introduction: Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independently

Palabras claves:

menopausal hormone therapy, MENOPAUSE, Type 2 Diabetes mellitus

Anagnostis P., Cano A., Goulis D.G., Jaremek J.D., Lambrinoudaki I., Lopes P., Meczekalski B., Mishra G.D., Mueck A., Paschou S.A., Peter A. Chedraui, Rees M., Rogowicz-Frontczak A., Senturk L.M., Simoncini T., Slopien R., Stevenson J.C., Stute P., Tuomikoski P., Wender-Ozegowska E., Zozulinska-Ziolkiewicz D.

Menopause symptom management in women with dyslipidemias: An EMAS clinical guide

Abstract: Introduction: Dyslipidemias are common and increase the risk of cardiovascular disease. The menopaus

Palabras claves:

Cardiovascular disease, Dyslipidemia(s), menopausal hormone therapy, MENOPAUSE, Premature menopause, statins

Anagnostis P., Bitzer J., Cano A., Ceausu I., Durmusoglu F., Erkkola R., Goulis D.G., Hirschberg A.L., Kiesel L., Lambrinoudaki I., Lopes P., Peter A. Chedraui, Pines A., Rees M., van Trotsenburg M.